Recommendations for post-discharge patient follow up after cardiac valve interventions: A position paper

Journal of Heart Valve Disease

Volumn 16, Issue 6, 2007, Pages 575-589

  Horstkotte, Dieter ^a   Lengyel, Maria ^b   Mistiaen, Wilhelm P ^c   Völler, Heinz ^d   Reibis, Rona ^d   Bogunovic, Nikola ^a   Faber, Lothar ^a   Hering, Detlef ^a   Piper, Cornelia ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Hungarian Institute of Cardiology   (Hungary)

^c Hogeschool Antwerpen   (Belgium)

^d Klinik am See   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ELECTROLYTE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; SOTALOL; SPIRONOLACTONE; WARFARIN;

ANTICOAGULANT THERAPY; AORTA VALVE STENOSIS; ARTICLE; BACTERIAL ENDOCARDITIS; COGNITIVE DEFECT; EMBOLISM; EMOTION; FIBROSING ALVEOLITIS; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEART VENTRICLE ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; INTRAVASCULAR HEMOLYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MITRAL VALVE REGURGITATION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PREGNANCY; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS INFECTION; PULMONARY HYPERTENSION; RESTENOSIS; SAINT JUDE HEART VALVE PROSTHESIS; STARR EDWARDS VALVE PROSTHESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; INTERNATIONAL NORMALIZED RATIO; POSTOPERATIVE COMPLICATIONS; THROMBOEMBOLISM;

EID: 36949002491     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (130)

1. Butchart EG, Gohlke-Baerwolf C, Antunes MJ, et al., and Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005;26:2463-2471
2. Horstkotte D. Heart valve consultant. ICR Publishers, London 1991:33-57
3. Horstkotte D. Point-of-care devices to improve long-term prognosis after valve replacement. J Heart Valve Dis 2005;14:472-475
4. Garcia-Orta R, Moreno E, Vidal M, et al. Three-dimensional versus two-dimensional transesophageal echocardiography in mitral valve repair. J Am Soc Echocardiogr 2007;20:4-12
5. De Carlo M, Milano A, Musumeci G, et al. Cardiopulmonary exercise testing in patients with 21 mm St. Jude Medical aortic prosthesis. J Heart Valve Dis 1999;8:522-528
6. Villari B, Vassalli G, Monrad ES, Chiariello M, Turina M, Hess OM. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation 1995;91:2353-2358
7. Gaudino M, Alessandrini F, Gheca F, et al. Survival after aortic valve replacement for aortic stenosis: Does left ventricular mass regression have a clinical correlate? Eur Heart J 2005;26:51-57
8. Lamb HJ, Beyerbacht HP, de Roos A, et al. Left ventricular remodeling early after aortic valve replacement: Differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. J Am Coll Cardiol 2002;40:2182-2188
9. Horstkotte D. Lebensqualität und Optimierung der Lebensqualität nach Herzklappeneratz. In: Blum U, von der Emde J (ed.), Diagnostik und operative Behandlung kardialer Erkrankungen. Steinkopff, Darmstadt, 1994:53-71
10. Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements;: A prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001;8:867-875
11. Djavidani B, Schmid FX, Keyser A, et al. Early regression of left ventricular hypertrophy after aortic valve replacement by the Ross procedure detected by cine MRI. J Cardiovasc Magnetic Res 2004;6:1-8
12. Horstkotte D, Haerten K, Seipel L. Central hemodynamics at rest and during exercise after mitral valve replacement with different prostheses. Circulation 1983;68:161
13. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary artery hypertension. J Am Coll Cardiol 2004;43:40S-47S
14. Faggiano P, Antonini-Canterin F, Ribichini F, et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 2000;85:204-208
15. Neumayer U, Schmidt HK, Fassbender D, Mannebach H, Bogunovic N, Horstkotte D. Early (three-month) results of percutaneous mitral valvotomy with the Inoue balloon in 1,123 consecutive patients comparing various age groups. Am J Cardiol 2002;90:190-193
16. Fawzy ME, Hassan W, Stefadouros M, Moursi M, El Shaer F, Chaudhary MA. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 2004;13:942-947
17. Zielinski T, Pogorelska H, Rajecka A, Biedermann A, Sliwinski M, Korewicki J. Pulmonary hemodynamics at rest and effort, 6-months and 12-months after mitral valve replacement - a slow regression of effort pulmonary hypertension. Int J Cardiol 1993;42:57-62
18. Krishnamoorthy KM, Dash PK, Radhakrishnan S, Shrivastava S. Response of different grades of pulmonary artery hypertension to balloon mitral valvuloplasty. Am J Cardiol 2002;90:1170-1173
19. Levine MJ, Weinstein JS, Diver DJ, et al. Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation 1989;79:1061-1067
20. Fawzy ME, Mimish L, Sivandandam V, et al. Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis. Am Heart J 1996;131:89-93
21. Umesan CV, Kapoor A, Sinha N, Kumar AS, Goel PK. Effect of Inoue balloon mitral valvotomy on severe pulmonary arterial hypertension in 315 patients with rheumatic mitral stenosis: Immediate and long-term results. J Heart Valve Dis 2000;9:609-615
22. Bahl VK, Chandra S, Talwar KK, Kaul U, Sharma S, Wasir HS. Balloon mitral valvotomy in patients with systemic and suprasystemic pulmonary artery pressures. Catheter Cardiovasc Diagnosis 1995;36:211-215
23. Elliott CG, Palevsky HI. Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis Thorax 2004;59:536-537
24. Kilner PJ. Pulmonary resistance in cardiovascular context. Int J Cardiol 2004;97:3-6
25. Li MZ, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 2005;45:1034-1040
26. Koch CG, Khandwala F, Estafanous FG, Loop FD, Blackstone EH. Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation 2005;21:3221
27. Baker RA, Andrew MJ, Knight JL. Evaluation of neurologic assessment and outcomes in cardiac surgical patients. Semin Thorac Cardiovasc Surg 2001;13:149-157
28. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
29. Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: Relation to neurocognitive function. Eur J Cardiothorac Surg 2005;28:88-96
30. Selnes CA, McKhann GM. Neurocognitive complications after coronary artery bypass surgery. Ann Neurol 2005;57:615-621
31. van Dijk D, Keizer AMA, Diephuis JC, et al. Neurocognitive dysfunction after coronary artery bypass surgery: A systematic review. J Thorac Cardiovasc Surg 2000;120:632-639
32. Mahanna EP, Blumenthal JA, White WD, et al. Defining neuropsychological dysfunction after coronary artery bypass grafting. Ann Thorac Surg 1996;61:1342-1347
33. Keith JR, Puente AE, Malcolmson KL, et al. Assessing postoperative cognitive change after cardiopulmonary bypass surgery. Neuropsychology 2002;16:411-421
34. Mullges W, Berg D, Schmidtke A, et al. Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med 2000;28:1808-1811
35. Selnes OA, Grega MA, Borowicz LM, Jr., et al. Cognitive changes with coronary artery disease: A prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg 2003;75:1377-1384
36. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med 2001;344:395-402
37. Hlatky MA, Bacon C, Boothroyd D, et al. Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. Circulation 1999;96:11-15
38. Potter GG, Plassman BL, Helms MJ, et al. Age effects of coronary artery bypass graft on cognitive status change among elderly male twins. Neurology 2004;63:2245-2249
39. Zimpfer D, Czerny M, Vogt F, et al. Neurocognitive deficit following coronary artery bypass grafting: A prospective study of surgical patients and nonsurgical controls. Ann Thorac Surg 2004;78:513-519
40. Mullges W, Babin-Ebell J, Reents W, Toyka KV. Cognitive performance after coronary artery bypass grafting: A follow-up study. Neurology 2002;59:741-743
41. Deklunder G, Roussel M, Lecroart JL, et al. Microemboli in cerebral circulation and alteration of cognitive abilities in patients with mechanical prosthetic heart valves. Stroke 1998;29:1821-1826
42. Kleine P, Perthel M, Hasenkam JM, et al. Downstream turbulence and high intensity transient signals (HITS) following aortic valve replacement with Medtronic Hall or St. Jude Medical valve substitutes. Eur J Cardiothorac Surg 2000;17:20-24
43. Kofidis T, Fischer S, Leyh H, et al. Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg 2002;21:22-26
44. Uekermann J, Suchan B, Daum I, et al. Neuropsychological deficits after mechanical aortic valve replacement. J Heart Valve Dis 2005;14:338-343
45. De Backer G, Ambrosioni E, Borch-Johnsen K, et al., and Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-1610
46. Smith SC, Jr., Allen J, Blair SN, et al. AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-2372
47. Morris JJ, Schaff HV, Mullany CJ, Morris PB, Frye RL, Orszulak TA. Gender differences in left ventricular functional response to aortic valve replacement. Circulation 1994;90:II183-II189
48. Chaput M, Bouchard D, Demers P, et al. Conversion to sinus rhythm does not improve long-term survival after valve surgery: Insights from a 20-year follow-up study. Eur J Cardiothorac Surg 2005;28:206-210
49. Sharony R, Grossi EA, Saunders PC, et al. Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg 2003;75:1808-1814
50. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993;15:1679-1683
51. Mistiaen WP, van Cauwelaert P, Muylaert P, Wuyts F, Bortier H. Risk factors for congestive heart failure after aortic valve replacement with a Carpentier-Edwards pericardial prosthesis in the elderly. J Heart Valve Dis 2005;14:774-779
52. Piper C, Körfer R, Horstkotte D. Prosthetic valve endocarditis. Heart 2001;85:590-593
53. Piper C, Hering D, Horstkotte D. Prosthetic valve thrombosis: Predisposition and diagnosis. Eur Heart J Suppl 2001;3:Q16-Q21
54. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). The Task force for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj /ehi205
55. Matsuyama K, Ueda Y, Ogino H, et al. Beta-blocker therapy in patients after aortic valve replacement for aortic regurgitation. Int J Cardiol 2000;31:49-53
56. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA 2005;294:3093-3100
57. Mooss AN, Wurdeman RL, Sugimoto JT, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: The Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004;148:641-648
58. Brembilla-Perrot B, Villemot JP, Carteaux JP, et al. Postoperative ventricular arrhythmias after cardiac surgery: Immediate- and long-term significance. Pacing Clin Electrophysiol 2003;26:619-625
59. Colli A, Gherli T, Mestres CA, Pomar JL. Degeneration of native and tissue prosthetic valve in aortic position: Do statins play an effective role in prevention? Int J Cardiol 2007;116:144-152
60. Cowell SJ, Newby DE, Prescott RJ, et al. Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-2397
61. Farivar RS, Cohn LH. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg 2003;126:969-975
62. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis. executive summary; The Task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-276
63. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease - native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004;126:457S-482S
64. Piper C, Horstkotte D. State of the art in anticoagulation management. J Heart Valve Dis 2004;13:S76-S80
65. Hering D, Piper C, Bergemann R, et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement. Results of the German Experience With Low Intensity Anticoagulation study. Chest 2005;127:53-59
66. Fitzmaurice D, Horstkotte D. Executive summary: Prevention of thromboembolic events: the role of point of care management. J Heart Valve Dis 2007;16:184-186
67. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998;5:S19-S24
68. Horstkotte D, Piper C. Improvement of oral anticoagulation therapy by INR self-management. J Heart Valve Dis 2004;13:335-338
69. Weller H, Dovifat C, Wegscheider K. Experience with INR self management: Patient selection and complication rates. Z Kardiol 2005;94:801-807
70. Voeller H, Dovifat C, Glatz J. Home management of anticoagulation. Eur Heart J Suppl 2001;3:Q44-Q49
71. Preiss M. Bernet F, Zerkowski HR. Additional information from the GELIA database: Analysis of benefit from self-management of oral anticoagulation (GELIA 6). Eur Heart J 2001;3:Q50-Q53
72. Voeller H, Dovifat C, Glatz L Koertke H, Taborski U, Wegscheider K. Self management of oral anticoagulation with the IN Ratio system: Impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004;11:442-447
73. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: A systematic review and meta-analysis. Lancet 2006;367:404-411
74. Horstkotte D, Hering D, Wiemer M, Piper C. Editorial: Discontinuing oral anticoagulation therapy. J Heart Valve Dis 2007;16:282-284
75. Aubert S, Barreda T, Acar C, et al. Mitral valve repair for commissural prolapse: Surgical techniques and long-term results. Eur J Cardiothorac Surg 2005;28:443-447
76. Braunberger E, Deloche A, Berrebi A, et al. Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in non-rheumatic mitral valve insufficiency. Circulation 2001;104:I8-I11
77. Gillinov AM, Cosgrove DM. Mitral valve repair for degenerative disease. J Heart Valve Dis 2002;11:S15-S20
78. Rankin JS, Orozco RE, Addai TR, et al. Several new considerations in mitral valve repair. J Heart Valve Dis 2004;13:399-409
79. Mantovani V, Mariscalco G, Leva C, Blanzola C, Cattaneo P, Sala A. Long-term results of the surgical treatment of chronic ischemic mitral regurgitation: Comparison of repair and prosthetic replacement. J Heart Valve Dis 2004;13:421-428
80. Flameng W, Herijgers P, Bogaerts, K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation 2003;107:1609-1613
81. Nishida H, Takahara Y, Takeuchi S, Mogi K. Mitral stenosis after mitral valve repair using the Duran flexible annuloplasty ring for degenerative mitral regurgitation. J Heart Valve Dis 2005;14:563-564
82. Quigley RL. Prevention of systolic anterior motion after repair of the severely myxomatous mitral valve with an anterior leaflet valvuloplasty. Ann Thorac Surg 2005;80:179-182
83. Inoue K. Percutaneous transvenous mitral commissurotomy using the Inoue balloon. Eur Heart J 1991;12:99-108
84. Tawn Z, Himbert D, Brochet E, Messika-Zeitoun D, lung B, Vahanian A. Percutaneous valve procedures: Present and future. Int J Cardiovasc Intervent 2005;7:14-20
85. Okamoto S, Inden M, Setsuda M, et al. Development of severe mitral regurgitation following percutaneous transvenous mitral valve commissurotomy. J Cardiol Suppl 1991;25:139-145
86. Bernard Y, Bassand JP, Schiele F, et al. Percutaneous mitral valvulotomy in non-optimal candidates. Eur Heart J 1991;12:90-94
87. Post J, Feldman T, Isner J, Herrmann H. Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. J Am Coll Cardiol 1995;25:1129-1136
88. Cequier A, Bonan R, Serra A, et al. Left-to-right atrial shunting after percutaneous mitral valvuloplasty. Incidence and long-term hemodynamic follow-up. Circulation 1990;81:1190-1197
89. Horstkotte D, Lengyel M. Mistiaen W, Piper C, Voller H, on behalf of the Working Group Infection Thrombosis, Embolism, and Bleeding of the Society of Heart Valve Disease. Recommendations for reporting morbid events after heart valve surgery. J Heart Valve Dis 2005;14:1-7
90. Horstkotte D, Piper C, Wagener J. Herzklappenfehler und Endokarditis. In: Burdach S et al. (ed.), Medizinische Therapie in Klinik und Praxis. Berlin, Springer, 2003:1183-1194
91. Horstkotte D, Bircks W, Loogen F. Infective endocarditis of native and prosthetic valves: The case for prompt surgical intervention? A retrospective analysis of factors affecting survival. Z Kardiol 1996;75:186
92. Dhasmana JP, Blackstone EH, Kirklin JW, Kouchoiukos NT. Factors associated with periprosthetic leakage following primary mitral valve replacement: With special consideration of the suture technique. Ann Thorac Surg 1983;35:170
93. Rizzoli G, Russo R, Resta M. Dehiscense of aortic valve prosthesis: Analysis of a ten-year experience. Int J Cardiol 1984;6:207
94. Rizzoli G, Russo R, Resta M. Mitral valve prosthesis dehiscence necessitating reoperation. An analysis of the involved risk factors. J Thorac Cardiovasc Surg 1983;31:91
95. Horstkotte D, Aul C, Seipel L. Influence of valve type and valve function on chronic intravascular hemolysis following mitral and aortic valve replacement using alloprostheses. Z Kardiol 1983;72:119-131
96. Griffiths BE, Charles R, Coulshed NB. Echophonocardiography in diagnosis of mitral perivalvular regurgitation with Björk-Shiley prosthetic valves. Br Heart J 1980;43:325
97. Horstkotte D. Curtius JM, Bircks. W, Loogen F. Noninvasive evaluation of prosthetic valves. In: Rabago G (ed.), Heart Valve Replacement. Current Status and Future Trends. Futura, New York, 1987
98. Worthley MI, Bayes AJ. Fluoroscopic evidence of prosthetic valve failure. Intern Med J 2006;36:618.
99. Fritzsche D, Eitz T, Minami K, et al. Digital frequency analysis of valve sound phenomena in patients after prosthetic valve surgery: Its capability as a true home monitoring of valve function. J Heart Valve Dis 2005;14:657-663
100. Mohammadi S, Baillot R, Voisine P, Mathieu P, Dagenais F. Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms. J Thorac Cardiovasc Surg 2006;132:401-406
101. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial. bioprosthesis. J Thorac Cardiovasc Surg 2002;124:146-154
102. David TE, Armstrong S, Sun Z. The Hancock II bioprosthesis at 12 years. Ann Thorac Surg 1998;66:S95-S98
103. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 2003;126:965-968
104. El Shaer F, Hassan W, Latroche B, et al. Pregnancy has no effect on the rate of structural deterioration of bioprosthetic valves: Long-term 18-year follow up results. J Heart Valve Dis 2005;14:481-485
105. Horstkotte D, Fassbender D., Piper C. Angeborene Herzfehler und erworbene Herzklappenfehler in der Schwangerschaft. Herz 2003;28:227-239
106. Antretter H, Bonatti J, Mair P, Profanter C, Trieb C, Dapunt OE. Bioprosthesis degeneration and reoperation in the aortic and mitral position. Wien Med Wochenschr 1995;145:147-150
107. Gulbins H, Kilian E, Roth S, Uhlig A, Kreuzer E, Reichart B. Is there an advantage in using homografts in patients with acute infective endocarditis of the aortic valve? J Heart Valve Dis 2002;11:492-497
108. Sievers HH, Hanke T, Stierle U, et al. A critical reappraisal of the Ross operation: Renaissance of the subcoronary implantation technique? Circulation 2006;114:I504-I511
109. Horstkotte D, Koerfer R. Prosthesis endocarditis with embolization of a Smeloff-Cutter aortic valve prosthesis. Diagnosis, surgical management, clinical and hemodynamic course up to 3 years' post-operative follow-up. Z Kardiol 1983;72:476-480
110. Laplace G, Lafitte S, Labeque JN, et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: A postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004;43:1283-1290
111. Lengyel M. Management of prosthetic valve thrombosis. J Heart Valve Dis 2004;13:329-334
112. Lengyel M, Horstkotte D, Voeller H, Mistiaen WP; Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005;14:567-575
113. lung B, Baron G, Butchart EG, et al. A prospective survey of patients with va1vular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243
114. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641
115. Grunkemeier GL, Wu YX. 'Our complication rates are lower than theirs': Statistical critique of heart valve comparisons. J Thorac Cardiovasc Surg 2003;125:290-300
116. Hering D, Piper C, Bergemann R, et al. Influence of two different reporting systems on counts of thromboembolic and bleeding complications after St. Jude Medical valve replacement: Results from the GELIA study. J Heart Valve Dis 2005;14:467-471
117. Levine MN, Raskob G, Beyth RJ, et al. Hemorrhagic complications of anticoagulant treatment. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:287S-310S
118. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:204S-233S
119. Horstkotte D, Schulte H, Bircks W, Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10-year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993;2:291-301
120. Pengo V, Barbero F, Banzato A, et al. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses. Thromb Haemost 1997;77:839-844
121. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006;48:1-148
122. De Caterina R, Husted S, Wallentin L, et al. Anticoagulants in heart disease: Current status and perspectives. Eur Heart J 2007;28:880-913
123. Hering D, Horstkotte D. Use of low-molecular weight heparins in patients with prosthetic heart valves. Dtsch Med Wochenschr 2003;128:1129-1133
124. Jafri SM. Periprocedural thromboprophylaxis in patients receiving anticoagulation therapy. Am Heart J 2004;147:3-15
125. Shapira Y, Vaturi M, Sagie A. Anticoagulant management of patients with mechanical prosthetic valves undergoing non-cardiac surgery: Indications and unresolved issues. J Heart Valve Dis 2001;10:380-387
126. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-1511
127. Horstkotte D, Bergemann R. Antithrombotic management after heart valve replacement: Results and consequences of the GELIA study. Eur Heart J Suppl 2001;3:Q1
128. Mahesh B, Evans S, Bryan AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002;11:745-750
129. Hering D, Piper C, Horstkotte D. Drug insight: An overview of current anticoagulation therapy after heart-valve replacement. Nat Clin Pract Cardiovasc Med 2005;2:415-422
130. Oakley C, Child A, Jung B et al. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-781